Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies - Report - MDSpire

Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies

  • By

  • Syed Gulfishan

  • Marya Ahsan

  • Md Ali Mujtaba

  • Pratibha Pandey

  • Meenakshi Verma

  • Sorabh Lakhanpal

  • Shivani Sharma

  • Mir Waqas Alam

  • Fahad Khan

  • June 5, 2026

Share

Regulation of microRNA in cancer through alkaloids: molecular mechanisms

Overview

This review evaluates the role of alkaloids in regulating microRNA expression and their effects on cancer progression. Alkaloids have shown significant anticancer potential by influencing various cellular processes and pathways associated with tumorigenesis.

Background

Cancer remains a leading cause of mortality globally, necessitating ongoing research into effective treatment strategies. The deregulation of microRNAs (miRNAs) is implicated in tumorigenesis and metastasis across various cancers. Alkaloids, derived from plants, have emerged as promising agents in cancer therapy due to their ability to modulate miRNA expression and impact cancer cell behavior.

Data Highlights

No numerical data or trial data is provided in the source material.

Key Findings

  • Alkaloids possess strong anticancer potential and have been developed into drugs such as vincristine and vinblastine.
  • These compounds can regulate miRNA expression, inhibiting cancer cell invasion and migration.
  • Alkaloids influence multiple cellular pathways associated with cancer, including apoptosis and cell cycle regulation.
  • Research indicates that miRNAs are key regulators in the anticancer mechanisms of alkaloids.
  • Plant-derived alkaloids are considered vital in the development of novel anticancer therapeutic agents.

Clinical Implications

The modulation of miRNA by alkaloids presents a potential avenue for enhancing cancer treatment efficacy. Understanding the mechanisms through which these compounds operate may inform future therapeutic strategies and adjunctive treatments in oncology.

Conclusion

Alkaloids represent a significant area of interest in cancer research due to their ability to regulate miRNA expression and influence tumor behavior. Continued exploration of these natural compounds may lead to improved therapeutic options for cancer patients.

Related Resources & Content

  1. Frontiers in Medicine, 2026 -- MicroRNAs in cancer: biogenesis, biomarkers and therapeutic strategies
  2. Frontiers in Oncology, 2026 -- miR-2110 orchestrates ERK–ELK1 transcriptional repression to induce cell-cycle arrest and enhance cytarabine sensitivity in acute myeloid leukemia
  3. Journal of Neuro-Oncology -- The involvement of microRNAs in the development of brain metastases
  4. Nature Reviews Clinical Oncology -- MicroRNAs in oncology: a translational perspective in the era of AI
  5. PMC -- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
  6. Assessment of miR-506 and miR-4316 Levels for Early and Non-Invasive Detection of Colorectal Cancer
  7. MicroRNAs in oncology: a translational perspective in the era of AI | Nature Reviews Clinical Oncology
  8. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours - PMC
  9. Frontiers | Matrine in cancer therapy: antitumor mechanisms and nano-delivery strategies

Original Source(s)

Related Content